Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Octavian Bucur

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Advances in Experimental Medicine and Biology|April 29, 2008
Apoptotic pathways in tumor progression and therapyArmelle Melet, Keli Song, Octavian Bucur, et al.
International Journal of Molecular Sciences|November 9, 2024
Space Travel: The Radiation and Microgravity Effects on the Cardiovascular SystemAndrei Alexandru Mircea, Dan Valentin Pistritu, Andra Fortner, et al.
Discoveries (Craiova, Romania)|August 18, 2015
PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressorOctavian Bucur, Andreea Lucia Stancu, Maria Sinziana Muraru, et al.
International Journal of Molecular Sciences|May 13, 2023
Vitamin C Regulates the Profibrotic Activity of Fibroblasts in In Vitro Replica Settings of Myocardial InfarctionYichen Xu, Huabo Zheng, Pakhwan Nilcham, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 7, 2013
Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIPOctavian Bucur, Bodvael Pennarun, Andreea Lucia Stancu, et al.
Plos One|October 25, 2013
Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cellsOctavian Bucur, Andreea Lucia Stancu, Ioana Goganau, et al.
International Journal of Molecular Sciences|January 10, 2026
The <i>CTDP1</i> Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic ApproachesIulia Maria Sabau, Alexandra Chera, Victor Gabriel Ungureanu, et al.
Molecular Biology of the Cell|January 30, 2010
Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKTAmrik Singh, Min Ye, Octavian Bucur, et al.
Nature Protocols|April 3, 2020
Nanoscale imaging of clinical specimens using conventional and rapid-expansion pathologyOctavian Bucur, Feifei Fu, Mike Calderon, et al.
Scientific Reports|May 12, 2015
A novel caspase 8 selective small molecule potentiates TRAIL-induced cell deathOctavian Bucur, Gabriel Gaidos, Achani Yatawara, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Advances in Experimental Medicine and Biology|April 29, 2008
Apoptotic pathways in tumor progression and therapyArmelle Melet, Keli Song, Octavian Bucur, et al.
International Journal of Molecular Sciences|November 9, 2024
Space Travel: The Radiation and Microgravity Effects on the Cardiovascular SystemAndrei Alexandru Mircea, Dan Valentin Pistritu, Andra Fortner, et al.
Discoveries (Craiova, Romania)|August 18, 2015
PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressorOctavian Bucur, Andreea Lucia Stancu, Maria Sinziana Muraru, et al.
International Journal of Molecular Sciences|May 13, 2023
Vitamin C Regulates the Profibrotic Activity of Fibroblasts in In Vitro Replica Settings of Myocardial InfarctionYichen Xu, Huabo Zheng, Pakhwan Nilcham, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 7, 2013
Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIPOctavian Bucur, Bodvael Pennarun, Andreea Lucia Stancu, et al.
Plos One|October 25, 2013
Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cellsOctavian Bucur, Andreea Lucia Stancu, Ioana Goganau, et al.
International Journal of Molecular Sciences|January 10, 2026
The <i>CTDP1</i> Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic ApproachesIulia Maria Sabau, Alexandra Chera, Victor Gabriel Ungureanu, et al.
Molecular Biology of the Cell|January 30, 2010
Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKTAmrik Singh, Min Ye, Octavian Bucur, et al.
Nature Protocols|April 3, 2020
Nanoscale imaging of clinical specimens using conventional and rapid-expansion pathologyOctavian Bucur, Feifei Fu, Mike Calderon, et al.
Scientific Reports|May 12, 2015
A novel caspase 8 selective small molecule potentiates TRAIL-induced cell deathOctavian Bucur, Gabriel Gaidos, Achani Yatawara, et al.
Pageof 4